The FDA has approved GSK’s Hibsago for adults with chronic hepatitis B virus infection who meet specific virological criteria ...
Sitryx Therapeutics has announced positive topline phase 1b results for SYX-5219, a first-in-class oral PKM2 modulator being ...
The FDA has approved Genentech’s Enspryng for adults with thyroid eye disease, making it the first at‑home subcutaneous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results